Factor | TGBD | Not TGBD | t / χ2 | P value |
---|---|---|---|---|
Male (%) | 18(81.8) | 91(58.3) | 0.740 | 0.390 |
Age, mean ± SD (years) | 45.58 ± 6.62 | 38.05 ± 7.61 | 3.045 |  < 0.001 |
BMI (%) | Â | Â | 4.315 | 0.038 |
 < 25 kg/m2 | 7(31.8) | 36(23) |  |  |
 > 25 kg/m2 | 15(68.1) | 120(76.9) |  |  |
Location of defects (%) | Â | Â | 4.233 | 0.040 |
 Femur | 16(76.1) | 11(7) |  |  |
 Tibia | 6(23.8) | 145(92.9) |  |  |
Type (%) | Â | Â | 0.201 | 0.654 |
 single level | 12(54.5) | 82(52.5) |  |  |
 double level | 10(45.4) | 74(47.4) |  |  |
Diabetes yes (%) | 9(40.9) | 58(37.1) | 4.813 | 0.028 |
Hypertension yes (%) | 4(18.1) | 39(25) | 0.868 | 0.351 |
Osteoporosis yes (%) | 16(72.7) | 49(31.4) | 5.064 | 0.024 |
Glucocorticoid intake yes (%) | 12(54.5) | 36(23) | 8.176 | 0.004 |
Duration of infection, mean ± SD (month) | 25 ± 8.02 | 23.61 ± 7.08 | 0.818 | 0.014 |
DS, mean ± SD (cm) | 6.11 ± 1.33 | 6.23 ± 1.30 | 0.940 | 0.340 |
BUT, mean ± SD (month) | 8.6 ± 0.50 | 7.99 ± 0.58 | 2.752 |  < 0.001 |
EFT, mean ± SD (month) | 9.51 ± 0.38 | 8.73 ± 0.65 | 3.668 |  < 0.001 |
EFI, mean ± SD (month/cm) | 1.99 ± 0.28 | 1.58 ± 0.40 | 2.912 |  < 0.001 |
Follow-up time (months) | 28.17 ± 4.29 | 28.64 ± 3.51 | 0.681 | 0.462 |